- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.93 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 8 x CU: COPPER (II) ION(Non-covalent)
- 17 x CDL: CARDIOLIPIN(Non-covalent)(Covalent)
CDL.3: 17 residues within 4Å:- Chain B: F.118, P.119, R.120, L.121, L.180
- Chain C: M.24, V.25, G.28, W.32, R.164, A.177, V.180, V.181, Y.184
- Chain D: A.86, I.122, V.129
Ligand excluded by PLIPCDL.4: 22 residues within 4Å:- Chain B: M.21, G.22, P.23, G.25, N.26, L.27, I.28, I.42, C.45, V.47, F.49, L.105, I.414, W.417, F.418, V.495, W.499, R.500
- Chain O: F.426, F.429, R.433
- Ligands: CDL.11
Ligand excluded by PLIPCDL.11: 23 residues within 4Å:- Chain B: M.21, K.24, V.46, F.496, K.497, R.500
- Chain G: I.45, M.48, H.49, G.51, G.52, S.55, V.87, R.89, N.90, R.94
- Chain O: I.381, M.384, P.425, Y.428, F.429, R.433
- Ligands: CDL.4
Ligand excluded by PLIPCDL.14: 17 residues within 4Å:- Chain I: F.118, P.119, R.120, L.121, L.180
- Chain J: V.25, G.28, T.29, W.32, E.36, H.150, R.164, A.177, V.180, Y.184
- Chain K: A.86, I.122
Ligand excluded by PLIPCDL.15: 22 residues within 4Å:- Chain I: M.21, G.22, P.23, K.24, G.25, N.26, L.27, I.28, I.42, V.47, F.49, L.105, I.414, W.417, F.418, V.495, W.499, R.500
- Chain R: F.426, F.429, R.433
- Ligands: CDL.22
Ligand excluded by PLIPCDL.22: 21 residues within 4Å:- Chain I: M.21, L.27, F.496, K.497, R.500
- Chain N: I.45, M.48, I.83, R.89, N.90, R.94, W.98, I.99
- Chain R: I.381, M.384, I.422, P.425, Y.428, F.429, R.433
- Ligands: CDL.15
Ligand excluded by PLIPCDL.26: 14 residues within 4Å:- Chain O: Y.25, A.30, R.33, Q.34, G.229, L.230, L.232, L.234, W.236, F.237
- Chain R: Y.25, H.26
- Ligands: MQ9.29, CDL.46
Ligand excluded by PLIPCDL.27: 17 residues within 4Å:- Chain O: H.42, W.43, F.134, R.371, P.372, R.373, I.386, I.430, T.431, W.434, C.435, L.438
- Chain Q: I.270, L.274, R.279
- Ligands: CDL.28, MQ9.38
Ligand excluded by PLIPCDL.28: 15 residues within 4Å:- Chain B: Y.29
- Chain D: W.90, I.93, L.97, S.98, F.120, T.123
- Chain O: R.373, W.434, L.438, L.489, K.491, R.492
- Ligands: CDL.27, CDL.36
Ligand excluded by PLIPCDL.33: 9 residues within 4Å:- Chain C: F.107, A.163, K.166, M.167
- Chain O: F.507
- Chain P: I.152, R.160
- Chain Q: W.275
- Ligands: CDL.36
Ligand excluded by PLIPCDL.36: 19 residues within 4Å:- Chain D: W.91, T.123, C.126, G.127, W.134, G.135, E.137
- Chain O: R.492, K.495
- Chain Q: I.263, V.267, I.270, G.271, L.272, L.274, W.275, R.279
- Ligands: CDL.28, CDL.33
Ligand excluded by PLIPCDL.43: 17 residues within 4Å:- Chain K: W.91, C.126, G.127, W.134, G.135
- Chain R: M.280, R.492, K.495
- Chain T: I.264, V.267, G.271, L.272, L.274, W.275, R.279
- Ligands: CDL.48, CDL.55
Ligand excluded by PLIPCDL.45: 12 residues within 4Å:- Chain O: T.144, L.151, F.346, V.347, A.351, F.354, K.357, R.358
- Chain R: D.20, R.24
- Ligands: MQ9.30, CDL.46
Ligand excluded by PLIPCDL.46: 14 residues within 4Å:- Chain O: Y.25, H.26
- Chain R: Y.25, A.30, L.31, R.33, Q.34, L.35, A.226, L.230, L.234, F.237
- Ligands: CDL.26, CDL.45
Ligand excluded by PLIPCDL.47: 14 residues within 4Å:- Chain R: H.42, W.43, F.134, R.371, P.372, R.373, I.386, T.431, W.434, C.435, L.438
- Chain T: R.279
- Ligands: CDL.48, MQ9.50
Ligand excluded by PLIPCDL.48: 16 residues within 4Å:- Chain I: Y.29
- Chain K: W.90, I.93, S.98, T.101, F.120
- Chain R: R.371, R.373, W.434, L.438, P.488, L.489, K.491, R.492
- Ligands: CDL.43, CDL.47
Ligand excluded by PLIPCDL.55: 18 residues within 4Å:- Chain J: F.107, L.155, V.156, L.160, A.163, K.166, M.167
- Chain K: C.126, F.130
- Chain R: L.279, S.506, F.507
- Chain S: W.99, L.145, I.152, R.160
- Chain T: W.275
- Ligands: CDL.43
Ligand excluded by PLIP- 4 x PLM: PALMITIC ACID(Non-covalent)
PLM.5: 1 residues within 4Å:- Chain G: F.75
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:F.75
PLM.16: 2 residues within 4Å:- Chain I: F.73, F.140
1 PLIP interactions:1 interactions with chain I- Hydrophobic interactions: I:F.140
PLM.25: 3 residues within 4Å:- Chain O: W.323, E.324, F.325
1 PLIP interactions:1 interactions with chain O- Hydrophobic interactions: O:F.325
PLM.44: 4 residues within 4Å:- Chain N: R.64
- Chain R: W.323, E.324, F.325
4 PLIP interactions:4 interactions with chain R- Hydrophobic interactions: R:W.323, R:W.323, R:W.323, R:F.325
- 4 x HEA: HEME-A(Non-covalent)(Covalent)
HEA.8: 21 residues within 4Å:- Chain A: I.106
- Chain B: W.151, W.260, V.267, Y.268, H.313, H.314, G.338, F.369, L.370, G.373, G.376, L.379, D.385, T.389, V.394, H.397, F.398, V.401, L.402, R.459
16 PLIP interactions:15 interactions with chain B, 1 interactions with chain A,- Hydrophobic interactions: B:W.151, B:V.267, B:F.369, B:L.370, B:L.379, B:V.394, B:F.398, B:V.401, B:L.402, A:I.106
- Hydrogen bonds: B:Y.268
- Salt bridges: B:R.459
- pi-Cation interactions: B:H.264, B:H.313, B:H.397
- Metal complexes: B:H.397
HEA.9: 23 residues within 4Å:- Chain B: G.56, L.57, A.59, L.60, M.62, R.63, F.83, H.86, M.90, L.91, W.151, I.395, F.398, H.399, L.402, F.403, F.446, Q.449, R.459, R.460, A.481, L.484, G.485
23 PLIP interactions:23 interactions with chain B,- Hydrophobic interactions: B:L.57, B:A.59, B:L.60, B:M.90, B:L.91, B:I.395, B:F.398, B:F.398, B:L.402, B:F.446, B:A.481
- Hydrogen bonds: B:F.83, B:W.151, B:Y.392, B:Q.449, B:R.460
- Salt bridges: B:R.459, B:R.460
- pi-Stacking: B:H.399, B:H.399, B:F.446
- Metal complexes: B:H.86, B:H.399
HEA.19: 21 residues within 4Å:- Chain H: I.105, I.106
- Chain I: W.151, W.260, V.267, H.313, H.314, G.338, F.369, L.370, G.373, G.376, L.379, D.385, T.389, V.394, H.397, F.398, V.401, L.402, R.459
18 PLIP interactions:16 interactions with chain I, 2 interactions with chain H,- Hydrophobic interactions: I:W.151, I:V.267, I:F.369, I:L.370, I:L.379, I:V.394, I:F.398, I:V.401, I:L.402, H:I.105, H:I.106
- Hydrogen bonds: I:H.313, I:T.389
- Salt bridges: I:R.459
- pi-Cation interactions: I:H.264, I:H.313, I:H.397
- Metal complexes: I:H.397
HEA.20: 23 residues within 4Å:- Chain I: G.56, L.57, A.59, L.60, M.62, R.63, F.83, H.86, M.90, L.91, W.151, I.395, F.398, H.399, L.402, F.403, F.446, Q.449, R.459, R.460, A.481, L.484, G.485
22 PLIP interactions:22 interactions with chain I,- Hydrophobic interactions: I:L.57, I:A.59, I:L.60, I:M.90, I:L.91, I:I.395, I:F.398, I:F.398, I:L.402, I:F.446, I:A.481
- Hydrogen bonds: I:F.83, I:W.151, I:Q.449, I:R.460
- Salt bridges: I:R.459, I:R.460
- pi-Stacking: I:H.399, I:H.399, I:F.446
- Metal complexes: I:H.86, I:H.399
- 2 x 9Y0: (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate(Non-covalent)
9Y0.10: 10 residues within 4Å:- Chain B: M.173
- Chain C: V.125, T.130, I.131, P.132, Y.141, G.145
- Chain D: A.102, A.103, A.106
No protein-ligand interaction detected (PLIP)9Y0.21: 10 residues within 4Å:- Chain I: M.173
- Chain J: V.125, T.130, I.131, P.132, Y.141, G.145
- Chain K: A.102, A.103, A.106
1 PLIP interactions:1 interactions with chain J- Hydrophobic interactions: J:Y.141
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.23: 20 residues within 4Å:- Chain O: F.45, G.48, F.121, I.125, H.128, L.129, R.131, I.132, A.137, R.142, N.145, W.146, G.149, L.152, H.231, L.232, V.235, H.240, T.241
- Ligands: MQ9.29
18 PLIP interactions:18 interactions with chain O,- Hydrophobic interactions: O:F.121, O:I.125, O:I.132, O:I.132, O:W.146, O:L.152, O:L.232, O:V.235, O:V.235
- Hydrogen bonds: O:G.48, O:R.131, O:T.241
- Salt bridges: O:H.128, O:R.131, O:R.142, O:H.240, O:H.240
- Metal complexes: O:H.231
HEM.24: 20 residues within 4Å:- Chain O: F.55, L.58, L.59, G.62, T.66, R.111, H.114, H.115, A.118, E.159, G.160, G.163, Y.164, L.166, P.167, H.216, I.217, P.221, N.287
- Chain R: L.218
15 PLIP interactions:14 interactions with chain O, 1 interactions with chain R,- Hydrophobic interactions: O:F.55, O:L.58, O:L.59, O:T.66, O:E.159, O:L.166, O:I.217, O:P.221, R:L.218
- Hydrogen bonds: O:N.287
- Salt bridges: O:R.111, O:R.111, O:H.115
- Metal complexes: O:H.114, O:H.216
HEM.41: 22 residues within 4Å:- Chain R: F.45, L.46, G.48, E.49, F.121, I.125, H.128, L.129, R.131, I.132, A.137, R.142, N.145, W.146, G.149, L.152, H.231, L.232, V.235, H.240, T.241
- Ligands: MQ9.30
19 PLIP interactions:19 interactions with chain R,- Hydrophobic interactions: R:F.121, R:I.125, R:L.129, R:I.132, R:I.132, R:W.146, R:L.152, R:L.232, R:V.235, R:V.235
- Hydrogen bonds: R:G.48, R:T.241
- Salt bridges: R:H.128, R:R.131, R:R.131, R:R.142, R:H.240, R:H.240
- Metal complexes: R:H.231
HEM.42: 19 residues within 4Å:- Chain O: L.218
- Chain R: F.55, L.58, L.59, G.62, V.63, T.66, R.111, H.114, H.115, A.118, E.159, G.160, G.163, Y.164, L.166, P.167, H.216, N.287
14 PLIP interactions:13 interactions with chain R, 1 interactions with chain O,- Hydrophobic interactions: R:F.55, R:L.58, R:L.59, R:V.63, R:E.159, R:Y.164, R:L.166, O:L.218
- Hydrogen bonds: R:N.287
- Salt bridges: R:R.111, R:R.111, R:H.115
- Metal complexes: R:H.114, R:H.216
- 8 x MQ9: MENAQUINONE-9(Non-covalent)(Covalent)
MQ9.29: 9 residues within 4Å:- Chain O: F.39, E.49, V.235, W.236, H.240, F.262
- Ligands: HEM.23, CDL.26, MQ9.53
3 PLIP interactions:3 interactions with chain O- Hydrophobic interactions: O:F.39, O:W.236, O:F.262
MQ9.30: 12 residues within 4Å:- Chain O: L.155, F.158, L.219
- Chain R: F.39, E.49, L.225, L.232, W.236, F.262
- Ligands: HEM.41, CDL.45, MQ9.49
8 PLIP interactions:5 interactions with chain R, 3 interactions with chain O- Hydrophobic interactions: R:F.39, R:L.225, R:L.232, R:F.262, O:L.155, O:F.158, O:L.219
- Hydrogen bonds: R:E.49
MQ9.37: 12 residues within 4Å:- Chain B: L.134, A.138
- Chain D: L.97, V.104, W.112
- Chain O: I.400, F.405, I.407
- Chain Q: Y.247, L.249, P.256, M.259
12 PLIP interactions:2 interactions with chain B, 6 interactions with chain D, 2 interactions with chain O, 2 interactions with chain Q- Hydrophobic interactions: B:L.134, B:A.138, D:L.97, D:V.104, D:W.112, O:I.400, O:I.407, Q:P.256, Q:P.256
- pi-Stacking: D:W.112, D:W.112, D:W.112
MQ9.38: 13 residues within 4Å:- Chain O: M.126, L.129, F.133, F.308, W.312, A.385, F.388, Y.389, M.390, T.393
- Chain Q: M.259, W.262
- Ligands: CDL.27
12 PLIP interactions:8 interactions with chain O, 4 interactions with chain Q- Hydrophobic interactions: O:L.129, O:F.133, O:F.308, O:W.312, O:F.388, O:Y.389, O:Y.389, O:T.393, Q:W.262, Q:W.262, Q:W.262
- pi-Stacking: Q:W.262
MQ9.49: 12 residues within 4Å:- Chain P: F.214, A.221, F.222
- Chain R: I.60, T.61, F.109, A.263, F.270
- Chain S: I.147, I.150, A.154
- Ligands: MQ9.30
11 PLIP interactions:5 interactions with chain R, 3 interactions with chain S, 3 interactions with chain P- Hydrophobic interactions: R:I.60, R:T.61, R:F.109, R:A.263, R:F.270, S:I.147, S:I.150, S:A.154, P:F.214, P:A.221, P:F.222
MQ9.50: 17 residues within 4Å:- Chain R: M.126, L.129, A.130, M.157, F.308, V.345, L.349, A.385, I.386, F.388, Y.389, M.390, T.393
- Chain T: M.259, W.262, I.270
- Ligands: CDL.47
15 PLIP interactions:12 interactions with chain R, 3 interactions with chain T- Hydrophobic interactions: R:L.129, R:A.130, R:F.308, R:V.345, R:L.349, R:I.386, R:F.388, R:Y.389, R:Y.389, R:Y.389, R:T.393, T:W.262, T:W.262, T:I.270
- Hydrogen bonds: R:Y.389
MQ9.53: 13 residues within 4Å:- Chain O: V.57, I.60, F.109, A.263, S.266, G.267, F.270
- Chain P: I.150, A.154
- Chain S: F.207, A.221, F.222
- Ligands: MQ9.29
11 PLIP interactions:6 interactions with chain O, 3 interactions with chain S, 2 interactions with chain P- Hydrophobic interactions: O:V.57, O:I.60, O:F.109, O:A.263, O:F.270, O:F.270, S:F.207, S:A.221, S:F.222, P:I.150, P:A.154
MQ9.59: 11 residues within 4Å:- Chain K: T.101, V.104, W.112
- Chain R: M.397, I.407, T.412
- Chain T: Y.247, L.249, G.250, P.256, M.259
8 PLIP interactions:1 interactions with chain R, 5 interactions with chain K, 2 interactions with chain T- Hydrophobic interactions: R:T.412, K:V.104, K:W.112, K:W.112, T:P.256, T:M.259
- pi-Stacking: K:W.112, K:W.112
- 2 x HV0: 5-methoxy-2-methyl-~{N}-[[4-[4-[4-(trifluoromethyloxy)phenyl]piperidin-1-yl]phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide(Non-covalent)
HV0.31: 15 residues within 4Å:- Chain O: Y.161, L.171, G.175, A.179, L.180, T.184, M.187, L.194, S.304, Q.305, P.306, M.310, T.313, E.314
- Chain P: H.375
5 PLIP interactions:5 interactions with chain O- Hydrophobic interactions: O:A.179, O:L.180
- Hydrogen bonds: O:T.313, O:T.313
- pi-Stacking: O:Y.161
HV0.51: 17 residues within 4Å:- Chain R: Y.161, L.171, G.175, A.179, L.180, T.184, M.187, L.194, S.304, Q.305, P.306, M.310, T.313, E.314, M.342
- Chain S: H.375
- Ligands: 9YF.54
3 PLIP interactions:3 interactions with chain R- Hydrophobic interactions: R:A.179, R:L.180
- Hydrogen bonds: R:T.313
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Covalent)
FES.32: 7 residues within 4Å:- Chain P: C.353, H.355, L.356, C.358, C.372, H.375, S.377
4 PLIP interactions:4 interactions with chain P,- Metal complexes: P:C.353, P:H.355, P:C.372, P:H.375
FES.52: 8 residues within 4Å:- Chain S: C.353, H.355, L.356, C.358, C.372, C.374, H.375, S.377
4 PLIP interactions:4 interactions with chain S,- Metal complexes: S:C.353, S:H.355, S:C.372, S:H.375
- 4 x 9YF: (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate(Non-covalent)(Covalent)
9YF.34: 4 residues within 4Å:- Chain P: W.231, W.246, E.425
- Ligands: 9YF.35
No protein-ligand interaction detected (PLIP)9YF.35: 10 residues within 4Å:- Chain O: W.193
- Chain P: G.224, G.225, I.227, K.228, N.229, K.232
- Chain R: R.105
- Chain S: W.119
- Ligands: 9YF.34
11 PLIP interactions:8 interactions with chain P, 1 interactions with chain R, 1 interactions with chain S, 1 interactions with chain O- Hydrophobic interactions: P:I.227, P:I.227, O:W.193
- Hydrogen bonds: P:G.224, P:G.225, P:I.227, P:K.228, P:N.229, S:W.119
- Salt bridges: P:K.232, R:R.105
9YF.54: 13 residues within 4Å:- Chain O: E.103, V.104, R.105
- Chain P: W.119
- Chain R: W.193, L.194
- Chain S: G.224, G.225, I.227, K.228, N.229, K.232
- Ligands: HV0.51
14 PLIP interactions:4 interactions with chain R, 5 interactions with chain S, 4 interactions with chain O, 1 interactions with chain P- Hydrophobic interactions: R:W.193, R:W.193, R:W.193, R:L.194, S:I.227
- Hydrogen bonds: S:G.225, S:K.228, S:N.229, O:E.103, O:R.105, O:R.105, P:W.119
- Salt bridges: S:K.232, O:R.105
9YF.56: 5 residues within 4Å:- Chain R: W.193
- Chain S: W.231, W.246, W.424, E.425
1 PLIP interactions:1 interactions with chain S- Hydrophobic interactions: S:W.231
- 4 x HEC: HEME C(Covalent)(Non-covalent)
HEC.39: 16 residues within 4Å:- Chain Q: S.72, C.73, C.76, H.77, H.87, P.89, L.91, V.94, A.98, V.99, V.103, M.108, P.109, A.110, I.132, Q.213
6 PLIP interactions:6 interactions with chain Q,- Hydrophobic interactions: Q:P.89, Q:L.91, Q:V.99, Q:V.103, Q:I.132
- Metal complexes: Q:H.77
HEC.40: 22 residues within 4Å:- Chain P: Y.363
- Chain Q: R.107, Q.116, R.119, N.173, C.174, C.177, H.178, L.187, Y.192, P.194, D.195, L.196, I.204, A.207, M.208, P.212, Q.213, M.215, P.216, F.218, I.231
16 PLIP interactions:16 interactions with chain Q,- Hydrophobic interactions: Q:L.187, Q:L.187, Q:L.196, Q:I.204, Q:A.207, Q:P.212, Q:Q.213, Q:M.215, Q:F.218, Q:I.231
- Hydrogen bonds: Q:D.195, Q:Q.213
- Salt bridges: Q:R.107, Q:R.107, Q:R.119
- Metal complexes: Q:H.178
HEC.57: 16 residues within 4Å:- Chain T: S.72, C.73, C.76, H.77, H.87, P.89, L.91, V.94, A.98, V.99, V.103, M.108, P.109, A.110, I.132, Q.213
8 PLIP interactions:8 interactions with chain T,- Hydrophobic interactions: T:C.73, T:C.76, T:P.89, T:L.91, T:V.99, T:V.103, T:I.132
- Metal complexes: T:H.77
HEC.58: 20 residues within 4Å:- Chain T: R.107, R.119, N.173, C.174, C.177, H.178, L.187, Y.192, P.194, D.195, L.196, I.204, A.207, M.208, P.212, Q.213, M.215, P.216, F.218, I.231
16 PLIP interactions:16 interactions with chain T,- Hydrophobic interactions: T:L.187, T:L.187, T:L.196, T:I.204, T:A.207, T:P.212, T:Q.213, T:M.215, T:F.218, T:I.231
- Hydrogen bonds: T:D.195, T:Q.213
- Salt bridges: T:R.107, T:R.107, T:R.119
- Metal complexes: T:H.178
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, S. et al., Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates. Elife (2021)
- Release Date
- 2021-10-27
- Peptides
- Cytochrome c oxidase subunit 2: AH
Cytochrome c oxidase subunit 1: BI
Cytochrome c oxidase subunit 3: CJ
Cytochrome c oxidase polypeptide 4: DK
Cytochrome c oxidase subunit CtaJ: EL
Uncharacterized protein MSMEG_4692/MSMEI_4575: FM
Prokaryotic respiratory supercomplex associate factor 1 PRSAF1: GN
Cytochrome bc1 complex cytochrome b subunit: OR
Cytochrome bc1 complex Rieske iron-sulfur subunit: PS
Cytochrome bc1 complex cytochrome c subunit: QT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EH
QB
FI
RC
GJ
SD
HK
TE
IL
UF
JM
VG
DN
PO
NR
BP
MS
AQ
OT
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.93 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 8 x CU: COPPER (II) ION(Non-covalent)
- 17 x CDL: CARDIOLIPIN(Non-covalent)(Covalent)
- 4 x PLM: PALMITIC ACID(Non-covalent)
- 4 x HEA: HEME-A(Non-covalent)(Covalent)
- 2 x 9Y0: (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 8 x MQ9: MENAQUINONE-9(Non-covalent)(Covalent)
- 2 x HV0: 5-methoxy-2-methyl-~{N}-[[4-[4-[4-(trifluoromethyloxy)phenyl]piperidin-1-yl]phenyl]methyl]pyrazolo[1,5-a]pyridine-3-carboxamide(Non-covalent)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Covalent)
- 4 x 9YF: (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate(Non-covalent)(Covalent)
- 4 x HEC: HEME C(Covalent)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, S. et al., Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates. Elife (2021)
- Release Date
- 2021-10-27
- Peptides
- Cytochrome c oxidase subunit 2: AH
Cytochrome c oxidase subunit 1: BI
Cytochrome c oxidase subunit 3: CJ
Cytochrome c oxidase polypeptide 4: DK
Cytochrome c oxidase subunit CtaJ: EL
Uncharacterized protein MSMEG_4692/MSMEI_4575: FM
Prokaryotic respiratory supercomplex associate factor 1 PRSAF1: GN
Cytochrome bc1 complex cytochrome b subunit: OR
Cytochrome bc1 complex Rieske iron-sulfur subunit: PS
Cytochrome bc1 complex cytochrome c subunit: QT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EH
QB
FI
RC
GJ
SD
HK
TE
IL
UF
JM
VG
DN
PO
NR
BP
MS
AQ
OT
C - Membrane
-
We predict this structure to be a membrane protein.